Table 1.
Malignancy | Patients with FFBLs suitable for analysis (n = 13) | Number of FFBLs included in analysis (n = 50) |
---|---|---|
Cervical/uterine cancer | 1 | 1 |
Lymphoma | 0 | 0 |
Head/neck SCC | 0 | 0 |
Multiple myeloma | 7 | 27 |
Lung cancer | 1 | 5 |
Vaginal/vulvar cancer | 0 | 0 |
Thyroid cancer | 1 | 5 |
Melanoma | 0 | 0 |
Sarcoma | 3 | 12 |
Other | 0 | 0 |
Abbreviations: FFBL – FDG-avid focal bone lesion; SCC – squamous cell carcinoma